Author: Andrew Horowitz

CNBC Portfolio Challenge Final Results – 2007

We ended with a $375,000 profit!

The 10 week contest is over and we came out in the top one percent of all portfolios. The fact is that we were as high as 900 and dropped down only during the final 2 weeks while still remaining in the top...

Read More

Dendreon – Is Provenge Snake Oil or Cure?

Dendreon Corporation (DNDN) took a huge fall the past few days after the FDA released an update to their “Approvable Letter”, asking for additional information regarding the efficacy of Provenge. This drug is, as most would say; “potentially revolutionary because it aims to teach the body’s own immune system to...

Read More

The Disciplined Investor Podcast – Episode 8

ARE WE CRAZY? What is going on in these markets… Time to protect portfolio…Markets are out of whack and we need to look at why that is.

The fact is that the extreme volatility we are seeing individual positions is reason to take a step back and look at what is...

Read More

MOTaIcahn and Très bien for Taser

Monday Merger Mania

Alcoa buying Alcan. Smart, accretive and a surprise. Amazingly, behind the scenes negotiations between these behemoths are looking like a smart move that will cut costs and help propel profits. The price being paid is rich, but it is one that will hopefully get the deal done with...

Read More

US Auto Industry:Adapt or Die!

CNBC Million Dollar Portfolio Challenge Update

The last week or so has proved to be rather difficult to pick a winner even in a thick field of news related announcements. Possibly due to the fact that there is no shortage of earnings announcements or just the simple fact that we are...

Read More